Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib effectively maintains hair regrowth in alopecia areata patients.

Using tazarotene with GliSODin improves facial skin more than tazarotene alone.

AI in dermatology is growing rapidly, showing promise in diagnosing skin conditions as accurately as dermatologists.

The TPAP method effectively categorizes androgenetic alopecia patients with high accuracy, but needs real-world validation.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Specific brain and bone imaging findings can help diagnose Trichothiodystrophy.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Tofacitinib citrate improved nail dystrophy and pain in patients with alopecia universalis without causing side effects.

Monitoring TGF-β and linc-PINT expression may help identify and treat high-risk heart arrhythmia patients.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Baricitinib is effective and cost-efficient for treating severe alopecia areata in adults.

AI is now essential in Indian aesthetic medicine.

AI improves cosmetic surgery but requires ethical and legal oversight to ensure safe use.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Ritlecitinib helps reduce inflammation and promote hair regrowth in alopecia areata, especially in patchy-type cases.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

JAK inhibitors can be safely used in alopecia areata patients with latent hepatitis B or tuberculosis, with proper monitoring.

Combining botulinum toxin type A with Minoxidil significantly improves hair growth and patient satisfaction in male hair loss.

Baricitinib effectively promotes hair regrowth in alopecia areata patients with mild side effects.

TH antibodies in vitiligo and AA patients recognize the same protein parts.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

A medicine called tofacitinib worked to treat a hair loss condition linked with a muscle and skin disease.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Both treatments help hair regrowth, but Botulinum Toxin-A has fewer side effects.

Baricitinib effectively regrows hair in severe alopecia areata cases.